What percentage drop in drug-related deaths do GLP-1s show?

Question

Accepted Answer

GLP-1 Agonists Linked to Significant Reduction in Drug-Related Deaths

A large-scale US study suggests that the use of GLP-1 agonists is associated with a substantial decrease in drug-related deaths among veterans. Specifically, for individuals with pre-existing drug addiction, taking these medications correlated with a 50% lower rate of death. This finding emerged from an analysis of medical records within the US Department of Veterans Affairs' healthcare database.
Reduced Mortality in Addicted Veterans

The research identified a notable 50% reduction in mortality rates for veterans already diagnosed with a drug addiction who were prescribed GLP-1 agonists. This significant decrease in deaths was observed over a three-year period, highlighting a potential protective effect of these medications against fatal outcomes associated with substance use disorders.
Lower Overdose Rates and Emergency Visits

Beyond mortality, the study also indicated a 40% lower rate of overdose among veterans with existing drug addiction who used GLP-1 agonists. Furthermore, emergency department visits related to substance use were over 30% lower, and hospital admissions and instances of suicidal thoughts or attempts decreased by a quarter in this cohort.
Prevention of New Addictions

The impact of GLP-1 agonists extended to veterans without a prior history of drug addiction. For this group, taking GLP-1s was linked to a 14% lower risk of developing a drug addiction. This suggests a potential preventative role for these medications in relation to substance use disorders across different populations within the study.

Reading history

Hide →

This history is cleared when the page is closed.

What percentage drop in drug-related deaths do GLP-1s show?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends